If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,068.00    14.50 (1.38%)
Bid:
1,066.00
Ask:
1,067.00
Spread: 1.00 (0.094%)
Market Cap: £3.43b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Dechra Pharmaceuticals

11 Jan 2024 18:00

RNS Number : 4516Z
FTSE Russell
11 January 2024

Further to the FTSE notice released on 09 January 2024 in relation to Dechra Pharmaceuticals (UK): Constituent Deletion, please note the replacement in the fixed indices.

All other details remain unchanged. Please see updated notice below:

Dechra Pharmaceuticals (UK): Constituent Deletion - UpdateChanges in FTSE UK Index Series

11 January 2024

Subject to court sanctioning the scheme of arrangement in relation to the cash offer for Dechra Pharmaceuticals (UK, constituent) by Freya Bidco Limited (non-constituent), please see details of affected indexes and effective dates below:

Dechra Pharmaceuticals (UK, 0963318) will be deleted from the index.

Persimmon PLC (UK, 0682538) will be added to the FTSE 100 Index and deleted from the FTSE 250 Index.

Baillie Gifford US Growth Trust (UK, BDFGHW4) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index.

All changes effective from 16 January 2024

Full details of index changes are available on the FTSE Russell website.

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+61 (0) 2 7228 5659

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1430

London

+44 (0) 20 7866 1810

New York

+1877 503 6437

Alternatively please visit our website at lseg.com/ftse-russell

Terms of Use | Copyright © 2024 FTSE Russell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FTSFLFLDLIILLIS
Date   Source Headline
1st Jun 20224:38 pmRNSBlock listing Interim Review
1st Jun 202210:52 amRNSTotal Voting Rights
17th May 202211:30 amRNSHolding(s) in Company
3rd May 20222:49 pmRNSTotal Voting Rights
27th Apr 20224:43 pmRNSResult of AGM
27th Apr 20227:00 amRNSTrading Statement
26th Apr 20229:55 amRNSHolding(s) in Company
20th Apr 20224:34 pmRNSHolding(s) in Company
5th Apr 202211:04 amRNSPersimmon signs UK Government’s Developer Pledge
1st Apr 202211:18 amRNSTotal Voting Rights
28th Mar 20224:30 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:30 pmRNSAnnual Report 2021 and Notice of AGM 2022
22nd Mar 20225:18 pmRNSDirector/PDMR Shareholding
9th Mar 20221:12 pmRNSDirector/PDMR Shareholding
2nd Mar 20227:00 amRNSFull Year Results
1st Mar 20223:34 pmRNSTotal Voting Rights
1st Feb 20221:58 pmRNSTotal Voting Rights
19th Jan 20223:37 pmRNSDirector/PDMR Shareholding
13th Jan 20227:04 amRNSAppointment of Chief Financial Officer
13th Jan 20227:00 amRNSTrading Statement
4th Jan 20224:50 pmRNSTotal Voting Rights
2nd Dec 202110:10 amRNSBlock listing Interim Review
1st Dec 202110:43 amRNSTotal Voting Rights
30th Nov 20212:33 pmRNSDirector/PDMR Shareholding
9th Nov 20217:00 amRNSTrading Statement
18th Aug 20217:00 amRNSHalf Year Results
27th Jul 20217:44 amRNSDirector Declaration
26th Jul 202111:02 amRNSFinance Director Succession
8th Jul 20217:00 amRNSTrading Update
1st Jul 20212:45 pmRNSTotal Voting Rights
25th Jun 20212:27 pmRNSAppointment of Independent Non-Executive Director
23rd Jun 20217:05 amRNSVoluntary Agreement With CMA
1st Jun 20214:24 pmRNSTotal Voting Rights
1st Jun 20212:15 pmRNSBlock listing Interim Review
21st May 20217:12 amRNSDirector Declaration
4th May 20211:09 pmRNSTotal Voting Rights
28th Apr 202112:33 pmRNSResult of AGM
28th Apr 20217:00 amRNSTrading Update
1st Apr 20213:52 pmRNSTotal Voting Rights
26th Mar 20211:20 pmRNSAnnual Report 2020 and Notice of AGM 2021
23rd Mar 20213:27 pmRNSDirector/PDMR Shareholding
23rd Mar 202111:09 amRNSDirector Declaration
22nd Mar 202111:01 amRNSDirector/PDMR Shareholding
8th Mar 20211:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNSFinal Results
1st Mar 20213:52 pmRNSTotal Voting Rights
10th Feb 20217:00 amRNSPersimmon Acts to Address Legacy Cladding Issues
1st Feb 20212:19 pmRNSTotal Voting Rights
13th Jan 20217:00 amRNSTrading Statement
4th Jan 20213:10 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.